抗病毒PROTACs:机遇与挑战相结合
Jinsen Liang1, Yihe Wu2, Ke Lan3
1Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, 430071, China.
Cell insight
|July 3, 2023
概括
蛋白质分解向仿真体 (PROTACs) 提供了一种新的抗病毒策略,但有限的配体和病毒突变等挑战阻碍了发展. 本综述探讨了抗病毒PROTACs的进展和局限性.
科学领域:
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
- 病毒学 病毒学
背景情况:
- 针对蛋白质溶解的仿真体 (PROTACs) 利用无素-蛋白酶体系统进行向蛋白质降解.
- PROTAC技术正在快速发展,许多候选人在临床试验中治疗各种疾病.
- 抗病毒PROTAC显示出希望,但由于特定的挑战,其落后于其他治疗领域.
研究的目的:
- 审查目前抗病毒PROTAC和相关药物的进展情况.
- 确定和分析阻碍有效抗病毒PROTACs开发的关键局限性.
- 总结设计原则和优化策略,为未来的抗病毒 PROTAC 开发.
主要方法:
- 对当前的抗病毒PROTAC和PROTAC类药物的文献综述.
- 对代表性实例及其生物活性进行分析.
- 检查常见的PROTAC缺陷和病毒突变挑战.
主要成果:
- 几种抗病毒PROTAC已经显示出对各种病毒有前途的生物活性.
- 关键的局限性包括结合体可用性有限,膜透性差,复杂的机制和病毒突变率.
- 该领域正在迅速发展,但与其他疾病领域相比,抗病毒PROTACs的数量仍然有限.
结论:
- 抗病毒PROTACs是一个有前途的治疗途径,但仍然存在重大障碍.
- 克服技术和生物挑战对于成功的抗病毒PROTAC开发至关重要.
- 战略设计和优化对于推动未来的抗病毒PROTAC研究和应用至关重要.
相关概念视频
Subviral Agents
45
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
45
Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Retrovirus Life Cycles
46.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.2K
Microorganisms in Medicine and Therapeutics
64
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
64


